Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Discovery & Development


Discovery & Development Dosage Forms

The New Filmmakers

| Angus Stewart

This Scottish company is developing a thin film that could improve medicine adherence in the elderly

Discovery & Development Clinical Trials

Data Damage

| Angus Stewart

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Discovery & Development Formulation

The Future of LNP Formulation technology for Pharma is Here

| Sponsored by KNAUER

More researchers are exploring the potential of mRNA encapsulation into lipid nanoparticles.

Discovery & Development Drug Discovery

The Final Frontier for Regenerative Medicine

| Stephanie Sutton

What will drug development look like aboard a new commercial space station?

Discovery & Development Analytical Science

Meet the Trendsetting Techniques of Biotherapeutic Molecule Characterization

| Eliza Lee

Advanced analytical technologies now offer the detailed assessments biopharma drug developers need.

Discovery & Development Drug Discovery

It’s Live: The Medicine Maker x DNDi Podcast

This 6 episode miniseries will take listeners behind the scenes of a range of projects at the Drugs for Neglected Diseases initiative

Discovery & Development Drug Discovery

Neurons: In the Know

| Jim Ross

How bioelectronic assays helped demonstrate the value of 3D iPSC cultures in modeling human brain development.

Discovery & Development Drug Discovery

Down with the Resistance

Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.

Discovery & Development Drug Discovery

A Little Byte of Life

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Discovery & Development Drug Discovery

Anthrax: an Unlikely Ally

| Angus Stewart

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register